Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
Kemps PG, Zondag TCE, Arnardóttir HB, Solleveld-Westerink N, Borst J, Steenwijk EC, van Egmond D, Swennenhuis JF, Stelloo E, Trambusti I, Verdijk RM, van Noesel CJM, Cleven AHG, Scheijde-Vermeulen MA, Koudijs MJ, Krsková L, Hawkins C, Egeler RM, Brok J, von Bahr Greenwood T, Svojgr K, Beishuizen A, van Laar JAM, Pötschger U, Hutter C, Sieni E, Minkov M, Abla O, van Wezel T, van den Bos C, van Halteren AGS. Kemps PG, et al. Among authors: van den bos c, van halteren ags, van egmond d, van laar jam, van wezel t, van noesel cjm. Blood Adv. 2023 Feb 28;7(4):664-679. doi: 10.1182/bloodadvances.2022007947. Blood Adv. 2023. PMID: 36083130 Free PMC article.
Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis.
Kemps PG, Zondag TC, Steenwijk EC, Andriessen Q, Borst J, Vloemans S, Roelen DL, Voortman LM, Verdijk RM, van Noesel CJM, Cleven AHG, Hawkins C, Lang V, de Ru AH, Janssen GMC, Haasnoot GW, Franken KLMC, van Eijk R, Solleveld-Westerink N, van Wezel T, Egeler RM, Beishuizen A, van Laar JAM, Abla O, van den Bos C, van Veelen PA, van Halteren AGS. Kemps PG, et al. Among authors: van den bos c, van halteren ags, van eijk r, van laar jam, van veelen pa, van wezel t, van noesel cjm. Front Immunol. 2020 Jan 10;10:3045. doi: 10.3389/fimmu.2019.03045. eCollection 2019. Front Immunol. 2020. PMID: 31998317 Free PMC article.
B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.
Kemps PG, Cleven AHG, van Wezel T, van Eijk R, Bot FJ, Veelken H, van Balen P, Kerkhoffs JH. Kemps PG, et al. Among authors: van eijk r, van wezel t, van balen p. Am J Hematol. 2020 Nov;95(11):1427-1429. doi: 10.1002/ajh.25801. Epub 2020 Apr 15. Am J Hematol. 2020. PMID: 32243611 Free PMC article. No abstract available.
NTRK fusions are extremely rare in bone tumours.
Lam SW, Briaire-de Bruijn IH, van Wezel T, Cleven AHG, Hogendoorn PCW, Cleton-Jansen AM, Bovée JVMG. Lam SW, et al. Among authors: van wezel t. Histopathology. 2021 Nov;79(5):880-885. doi: 10.1111/his.14432. Epub 2021 Sep 3. Histopathology. 2021. PMID: 34148257 Free PMC article.
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.
de Groen RAL, van Eijk R, Böhringer S, van Wezel T, Raghoo R, Ruano D, Jansen PM, Briaire-de Bruijn I, de Groot FA, Kleiverda K, Te Boome L, Terpstra V, Levenga H, Nicolae A, Posthuma EFM, Focke-Snieders I, Hardi L, den Hartog WCE, Bohmer LH, Hogendoorn PCW, van den Berg A, Diepstra A, Nijland M, Lugtenburg PJ, Kersten MJ, Pals ST, Veelken H, Bovée JVMG, Cleven AHG, Vermaat JSP. de Groen RAL, et al. Among authors: van eijk r, van wezel t, van den berg a. Blood Adv. 2021 Oct 12;5(19):3760-3775. doi: 10.1182/bloodadvances.2021005215. Blood Adv. 2021. PMID: 34478526 Free PMC article.
Synchronous diffuse large B-cell lymphoma and mantle cell lymphoma: support for low-threshold biopsies and genetic testing.
de Groot FA, de Haan LM, de Groen RAL, Heijmen L, van Wezel T, van Eijk R, Bohmer L, Bot F, Ten Berge RL, Diepstra A, Veelken H, Cleven AHG, Jansen PM, Vermaat JSP. de Groot FA, et al. Among authors: van eijk r, van wezel t. Leuk Lymphoma. 2022 May;63(5):1251-1255. doi: 10.1080/10428194.2021.2015589. Epub 2021 Dec 21. Leuk Lymphoma. 2022. PMID: 34933651 No abstract available.
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.
Hondelink LM, Schrader AMR, Asri Aghmuni G, Solleveld-Westerink N, Cleton-Jansen AM, van Egmond D, Boot A, Ouahoud S, Khalifa MN, Wai Lam S, Morreau H, Bovee JVMG, van Wezel T, Cohen D. Hondelink LM, et al. Among authors: van egmond d, van wezel t. Eur J Cancer. 2022 Sep;173:229-237. doi: 10.1016/j.ejca.2022.06.030. Epub 2022 Aug 4. Eur J Cancer. 2022. PMID: 35933886 Free article.
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring.
Schrader AMR, de Groen RAL, Willemze R, Jansen PM, Quint KD, Cleven AHG, van Wezel T, van Eijk R, Ruano D, Veelken JHH, Tensen CP, Neelis KJ, Daniels LA, Hauben E, Woei-A-Jin FJSHS, Busschots AMA, Vermeer MH, Vermaat JSP. Schrader AMR, et al. Among authors: van eijk r, van wezel t. Cancers (Basel). 2022 Oct 20;14(20):5152. doi: 10.3390/cancers14205152. Cancers (Basel). 2022. PMID: 36291936 Free PMC article.
203 results